Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support
Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...
488 Views
Bayer AG has reported its first quarter results for 2025
Bayer AG has reported its first quarter results for 2025, revealing a mixed performance across its business divisions amidst challenging...
363 Views
Syngenta Pre-IPO - The Negatives - Margins Remain Razor Thin and Parent on Sanction List
Syngenta Group (1844795D CH) is looking to raise around US$9.2bn in its upcoming China A-share IPO. In this note, we will talk about the not so...
526 Views
Syngenta Pre-IPO - The Positives - Giant in the Agriculture Industry Set to Benefit from Policies
Syngenta Group (1844795D CH) is looking to raise around US$9.2bn in its upcoming China A-share IPO. In this note, we will talk about the positive...
635 Views
CRISPR Therapeutics AG (CRSP US): First Genome Editing Based Drug Candidate Seeking FDA Approval
CRISPR completed regulatory submissions for exa-cel (world’s first CRISPR gene editing drug) in US and awaits FDA action date. Exa-cel has the...
685 Views